Jianli Wang Selected Research

lymphotactin

4/2011	Reduced tumorigenesis of EG7 after interleukin-10 gene transfer and enhanced efficacy in combination with intratumorally injection of adenovirus-mediated lymphotactin and the underlying mechanism.
9/2002	Adenovirus-mediated intratumoral lymphotactin gene transfer potentiates the antibody-targeted superantigen therapy of cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianli Wang Research Topics

Disease

34	Neoplasms (Cancer) 01/2022 - 09/2002
10	Inflammation (Inflammations) 01/2021 - 07/2006
8	Leukemia 01/2021 - 01/2005
7	Infections 07/2022 - 01/2013
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2020 - 01/2010
5	Sepsis (Septicemia) 03/2021 - 09/2013
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2018 - 01/2013
4	Multiple Myeloma 12/2019 - 06/2012
4	Hyperplasia 10/2018 - 04/2010
4	Neointima 05/2017 - 04/2010
4	Breast Neoplasms (Breast Cancer) 01/2017 - 04/2012
4	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 04/2005
3	Pathologic Constriction (Stenosis) 01/2022 - 05/2021
3	Hypersensitivity (Allergy) 02/2020 - 12/2014
3	Residual Neoplasm 01/2020 - 01/2013
3	Carcinogenesis 01/2020 - 06/2007
3	Colitis 01/2018 - 01/2013
3	Neoplasm Metastasis (Metastasis) 01/2015 - 06/2012
3	Experimental Melanoma 07/2005 - 09/2002
2	Mental Disorders (Mental Disorder) 11/2021 - 12/2019
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2021 - 12/2011
2	Stomach Neoplasms (Stomach Cancer) 04/2021 - 01/2021
2	COVID-19 04/2021 - 07/2020
2	Hypoxia (Hypoxemia) 01/2021 - 01/2019
2	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 01/2021 - 06/2017
2	Brain Edema (Cerebral Edema) 01/2020 - 01/2005
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 01/2014
2	Bacterial Infections (Bacterial Infection) 01/2018 - 01/2018
2	Asthma (Bronchial Asthma) 01/2018 - 05/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2014 - 01/2013
2	Carcinoma (Carcinomatosis) 12/2011 - 09/2002
2	Lymphoma (Lymphomas) 06/2006 - 01/2005
1	Genomic Instability 10/2022
1	Suppuration 04/2022
1	Obstructive Sleep Apnea 01/2022

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2012
10	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2002
9	AntigensIBA 01/2021 - 09/2002
8	CytokinesIBA 01/2018 - 09/2002
5	Cancer VaccinesIBA 09/2012 - 09/2003
4	VaccinesIBA 04/2021 - 09/2003
4	Therapeutic UsesIBA 03/2021 - 01/2013
4	Interleukin-10 (Interleukin 10)IBA 03/2021 - 04/2011
4	Peptides (Polypeptides)IBA 01/2021 - 01/2002
4	Messenger RNA (mRNA)IBA 01/2021 - 01/2007
4	Interleukin-6 (Interleukin 6)IBA 01/2017 - 09/2013
3	LipidsIBA 01/2022 - 01/2007
3	CX 5461IBA 01/2021 - 03/2017
3	Pharmaceutical PreparationsIBA 12/2020 - 01/2013
3	Transforming Growth Factor beta1 (TGF beta 1)IBA 02/2020 - 01/2010
3	SuperantigensIBA 02/2020 - 09/2002
3	Immunoglobulin E (IgE)IBA 09/2018 - 12/2014
3	Biological ProductsIBA 03/2017 - 12/2011
3	C-Reactive ProteinIBA 10/2015 - 01/2013
3	Interferon-gamma (Interferon, gamma)IBA 09/2012 - 07/2005
2	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 01/2022
2	Oxygen (Dioxygen)IBA 01/2022 - 10/2019
2	Amino Acids FDA Link 01/2022 - 12/2014
2	AntioxidantsIBA 01/2022 - 01/2017
2	3,4-methylenedioxyethamphetamine (MDEA)IBA 11/2021 - 06/2005
2	CateninsIBA 04/2021 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2021 - 09/2013
2	salicylhydroxamic acid (SHAM)IBA 03/2021 - 12/2020
2	EpitopesIBA 01/2021 - 12/2014
2	RNA Polymerase I (Polymerase I, RNA)IBA 01/2021 - 03/2017
2	HLA-A*02:01 antigenIBA 01/2021 - 12/2014
2	RNA (Ribonucleic Acid)IBA 01/2020 - 12/2011
2	Long Noncoding RNAIBA 03/2018 - 02/2018
2	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 06/2012
2	Interferon Type IIBA 11/2016 - 01/2013
2	Dextran SulfateIBA 10/2016 - 01/2013
2	Tumor Biomarkers (Tumor Markers)IBA 12/2015 - 06/2012
2	Dopamine (Intropin)FDA LinkGeneric 02/2014 - 11/2012
2	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2013 - 01/2007
2	Interleukin-18 (Interleukin 18)IBA 01/2013 - 09/2003
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 06/2012 - 01/2007
2	LipopolysaccharidesIBA 05/2012 - 01/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2011 - 04/2011
2	lymphotactinIBA 04/2011 - 09/2002
2	Interleukin-2 (IL2)IBA 06/2007 - 05/2007
2	Staphylococcal enterotoxin AIBA 05/2007 - 09/2002
1	Melanins (Melanin)IBA 10/2022
1	Adenosine Monophosphate (AMP)IBA 07/2022
1	SulfonamidesIBA 04/2022
1	oxidized low density lipoproteinIBA 01/2022
1	TrisaccharidesIBA 01/2022
1	baysilon (polydimethylsiloxane)IBA 01/2022
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2022
1	Air Pollutants (Pollutants, Air)IBA 01/2022
1	OligosaccharidesIBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2022

Therapy/Procedure

14	Therapeutics 01/2022 - 09/2002
6	Drug Therapy (Chemotherapy) 01/2019 - 01/2013
5	Immunotherapy 01/2021 - 09/2002
4	Ligation 03/2021 - 01/2019
3	Punctures 03/2021 - 04/2020
3	Transplantation 05/2017 - 08/2002
2	Stents 05/2021 - 01/2021
2	Hysterectomy 05/2021 - 01/2021